Anti-VEGF antibodies and uses thereof

Provided are monoclonal antibodies and antigen binding fragments thereof that specifically bind vascular endothelial growth factor (VEGF). The anti-VEGF monoclonal antibodies block VEGF binding to its receptors (e.g., VEGFR1 and/or VEGFR2) and prevent phosphorylation of VEGFR2 by VEGF. Also provided...

Full description

Saved in:
Bibliographic Details
Main Authors CROY, LESLIE A, SMITH, ERNEST S, PARIS, MARK J
Format Patent
LanguageEnglish
Published 10.01.2013
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract Provided are monoclonal antibodies and antigen binding fragments thereof that specifically bind vascular endothelial growth factor (VEGF). The anti-VEGF monoclonal antibodies block VEGF binding to its receptors (e.g., VEGFR1 and/or VEGFR2) and prevent phosphorylation of VEGFR2 by VEGF. Also provided are methods of using the monoclonal anti-VEGF antibodies for treatment of disease, including cancer.
AbstractList Provided are monoclonal antibodies and antigen binding fragments thereof that specifically bind vascular endothelial growth factor (VEGF). The anti-VEGF monoclonal antibodies block VEGF binding to its receptors (e.g., VEGFR1 and/or VEGFR2) and prevent phosphorylation of VEGFR2 by VEGF. Also provided are methods of using the monoclonal anti-VEGF antibodies for treatment of disease, including cancer.
Author SMITH, ERNEST S
CROY, LESLIE A
PARIS, MARK J
Author_xml – fullname: CROY, LESLIE A
– fullname: SMITH, ERNEST S
– fullname: PARIS, MARK J
BookMark eNrjYmDJy89L5WRQdcwrydQNc3V3U0gEspLyUzJTi4HMFIXSYiCjJCO1KDU_jYeBNS0xpziVF0pzMyi7uYY4e-imFuTHpxYXJCan5qWWxDuGGhkYGhqZmVuYWToaGhOnCgBsoSkR
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2011267869A1
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2011267869A13
IEDL.DBID EVB
IngestDate Fri Jul 19 16:00:19 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2011267869A13
Notes Application Number: AU20110267869
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130110&DB=EPODOC&CC=AU&NR=2011267869A1
ParticipantIDs epo_espacenet_AU2011267869A1
PublicationCentury 2000
PublicationDate 20130110
PublicationDateYYYYMMDD 2013-01-10
PublicationDate_xml – month: 01
  year: 2013
  text: 20130110
  day: 10
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies VACCINEX, INC
RelatedCompanies_xml – name: VACCINEX, INC
Score 2.8728163
Snippet Provided are monoclonal antibodies and antigen binding fragments thereof that specifically bind vascular endothelial growth factor (VEGF). The anti-VEGF...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Anti-VEGF antibodies and uses thereof
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130110&DB=EPODOC&locale=&CC=AU&NR=2011267869A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTYwSjMyNTLVTQK2JXRNDC1SdJMMzIx0zVLSzEBdsURLA9AGZ18_M49QE68I0wgmhhzYXhjwOaHl4MMRgTkqGZjfS8DldQFiEMsFvLayWD8pEyiUb-8WYuuiBu0dG4KSq4Gai5Ota4C_i7-zmrMzsCep5hcEHgo0AhbMZpaOwL4SK7AhbQ7utoU5gfalFCBXKm6CDGwBQPPySoQYmFLzhBk4nWF3rwkzcPhCp7yBTGjuKxZhUHXMK8nUDXN1d1MAhkdmUj5oBSCQmaJQWgxkgJpyqflpogzKbq4hzh66QPvi4d6LdwxFdpyxGAMLsOOfKsGgkARsnhhbAitVE9DkoEmSpUWiuWWaQZopsFI1skhOkmSQwWeSFH5paQYuI_DVDqAlbTIMLCVFpamywAq2JEkOHC4A5IV7Wg
link.rule.ids 230,309,783,888,25577,76883
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2K1akDNLZhuk5gciqR5GLVJi6Slt9DNAwKSFJPi33d2SbWn3oZd2Mew8_h2ZnYBHmKZZEQlqkTRl5CUgZ5IVNaIpCWZxqDYypBZgbMfaN5ceV-qyxZ8bWth-DuhP_xxRJSoGOW95vp6_X-JZfPcyuqJ5thUvrjhyBYbdDxgx1UW7fHImU3tqSVaFiJJMfjkV4EEFbNmmIiVDtDJ1jlYWoxZXcp616i4J3A4w_GK-hRaadGFjrX9e60LR34T8kaykb7qDB7Nos6lhfPqCsiPnJYsAxDJRNhUSDBXLi2zc7h3ndDyJJwv-tteZM53Fze8gDYC__QSBIruydBAo6qw4KBCDX31bGRypqJRJXpMe9DfN9LV_u476HihP4kmb8HHNRwT_s0DS2_rQ7v-3qQ3aGxrest59AvVXX5K
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Anti-VEGF+antibodies+and+uses+thereof&rft.inventor=CROY%2C+LESLIE+A&rft.inventor=SMITH%2C+ERNEST+S&rft.inventor=PARIS%2C+MARK+J&rft.date=2013-01-10&rft.externalDBID=A1&rft.externalDocID=AU2011267869A1